Leo Pharma

From Wikipedia, the free encyclopedia
  (Redirected from LEO Pharma)
Jump to: navigation, search
Leo Pharma A/S
Aktieselskab A/S Danish Public Limited stock based corporation
Industry Pharmaceutical industry
Founded 1908
Founder August Kongsted and Anton Antons
Headquarters Ballerup, Copenhagen, Denmark
Area served
Key people
Gitte Aabo (CEO)
Products Prescription drugs for dermatology, bone remodeling thrombosis and coagulation
Revenue Increase 7.973 billion DKK (2014)[1]
Total assets Decrease 31.627 billion DKK (2014)[1]
Number of employees
Decrease 4,712 (2014)[1]
Website Home Page
Footnotes / references
Wholly owned by a foundation (nonprofit)

Leo Pharma A/S is a multinational Danish pharmaceutical company, founded in 1908, with a presence in about 100 countries. Its headquarters are in Ballerup, near Copenhagen[2] The company is 100% integrated into a private foundation owned by the LEO Foundation.[3] Leo Pharma develops and markets products for dermatology, bone remodeling thrombosis and coagulation.[4] In 1945 it was the first producer of penicillin outside the USA and UK.


Formation & the 20th Century[edit]

In 1908, pharmacists August Kongsted and Anton Antons bought the LEO Pharmacy in Copenhagen, Denmark. With the purchase, they established 'Københavns Løveapoteks kemiske Fabrik', today known as LEO Pharma. LEO Pharma celebrated its centennial in 2008. Flags bearing the LEO logo were flying in every country where LEO products are available, more than a hundred flags in total. Today, LEO Pharma has an ever growing pipeline with over 4,800 specialists focussing on dermatology and thrombosis.

  • 1912 – The company launched its own Aspirin headache tablet
  • 1917 – The company exported Denmarks first drug, Digisolvin
  • 1940 – The company launched its own Heparin product.
  • 1958-08-13 - Patent filed for Bendrofluazide.[5]
  • 1962 – The company launched Fucidin to be used to treat staphylococcus infections

21st Century & onwards[edit]

In 2015, the company announced it would acquire Astellas Pharmas dermatology business for $725 million.[6]